Phase 3 Readout~month
Phase 3 Topline: A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phas
- Company
- Kodiak Sciences Inc. (KOD)
- Drug
- intravitreal
- Indication
- Wet Age-related Macular Degeneration
Other upcoming events for KOD
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.